Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 76 to 100 of 383

TitlePrioritisation programmeDecisionDecision date
Veverimer for treating metabolic acidosis in chronic kidney disease [ID3832]None selectedAwaiting decision
Transoral endoscopic thyroid surgery via a vestibular approachNone selectedNot selected
Transoral Endoscopic Thyroid/Parathyroid Vestibular ApproachNone selectedNot selected
Levodopa inhaled for patients with Parkinson's disease who experience 'off' episodes (motor response fluctuations) [TSID8778]None selectedNot selected
Linaclotide acetate for treating functional constipation in people 6 to 17 years [TSID12125]None selectedNot selected
Vedolizumab for treating moderately to severely active ulcerative colitis in people 2 to 17 years [TSID12134]None selectedNot selected
Eptinezumab for preventing cluster headache attacks TSID 12087None selectedAwaiting decision
Paediatric lymphatic interventions (mainly Percutaneous thoracic duct embolisation) for Chylothorax, chylous ascites, plastic bronchitis, chylopericardium, Chyluria, Protein losing enteropathyNone selectedNot selected
High resolution anoscopy and laser therapy for intraepithelial neoplasia of the anus in high risk or immunocompromised patientsNone selectedAwaiting decision
Multi-vessel minimal access coronary artery surgery for multi-vessel coronary artery diseaseNone selectedAwaiting decision
Diclofenac–clotrimazole for Vulvovaginal candidiasis (VVC) [TSID 12053]None selectedNot selected
Clindamycin for treating bacterial vaginosis in females aged 12 and older [TSID 12127]None selectedNot selected
Ustekinumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years [TSID 12128]None selectedNot selected
Berotralstat for preventing recurrent attacks of hereditary angioedema in children aged 2 to 12 years [TSID 12132]None selectedNot selected
Lebrikizumab for treating atopic dermatitis in children [TSID12133]None selectedNot selected
Lebrikizumab for treating atopic dermatitis in children [TSID 12133_TSID 12135]None selectedNot selected
Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more treatments (review of TA881) [ID6496]None selectedAwaiting decision
Avatrombopag for treating primary chronic immune thrombocytopenia in people 1 to 17 years [TSID12109]None selectedNot selected
NVK-002 for treating myopia in people 3 to 17 years [TSID11961]None selectedNot selected
Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353None selectedNot selected
Transbronchial lung cryobiopsyNone selectedAwaiting decision
Noninvasive Vagus Nerve Stimulation For reactive airway diseaseNone selectedFurther information required
Selumetinib granules for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children 1 to 6 years [TSID12092]None selectedNot selected
Entrectinib for treating NTRK fusion-positive solid tumours in people 1 month to 11 years [TSID12116]None selectedNot selected
Prolonged-release diazoxide choline for treating Prader-Willi syndrome [ID1389]None selectedAwaiting decision

Results per page

  1. 10
  2. 25
  3. 50
  4. All